胰高血糖素样肽-1可预测急性呼吸衰竭患者的死亡率
该回顾性队列研究纳入297例UPMC西部宾夕法尼亚医院ICU的急性呼吸衰竭危重成人,测量入组时基线GLP-1与GIP水平。结果发现非存活者及有急性呼吸窘迫综合征或高危患者GLP-1水平高于因气道保护插管者,GLP-1与全身免疫反应标志物正相关,与肠道通透性标志物无关。GLP-1与90天死亡率在未校正(OR 1.99)和校正年龄、SOFA评分、IL-6后(OR 2.02)均正相关,GIP与死亡率及宿主反应标志物无关。作者认为循环GLP-1升高可能作为预后生物标志物识别预后更差的患者。
要点
- 在297例急性呼吸衰竭危重成人中,基线GLP-1与90天死亡率正相关:未校正OR 1.99(95%CI 1.55-2.56),校正年龄、SOFA评分、IL-6后OR 2.02(95%CI 1.23-3.31)。
- GIP水平与90天死亡率无关联,也与宿主反应标志物无关联。
- 非存活者及有急性呼吸窘迫综合征或高危患者的GLP-1水平高于因气道保护插管者。
- GLP-1水平与全身免疫反应生物标志物正相关,但与肠道通透性标志物无关。
- 作者认为循环GLP-1升高可能作为预后生物标志物,用于识别急性呼吸衰竭危重患者中预后更差者。
适用人群与场景
- UPMC卫生系统西部宾夕法尼亚医院ICU的297例急性呼吸衰竭危重成人。
- 基线样本于研究入组时采集。
研究设计与关键结果
- 研究类型为回顾性队列研究,样本量297例急性呼吸衰竭危重成人,设置于UPMC卫生系统西部宾夕法尼亚医院ICU。
- 非存活者及有急性呼吸窘迫综合征或高危患者的GLP-1水平高于因气道保护插管者。
- GLP-1水平与全身免疫反应生物标志物正相关,与肠道通透性标志物无关。
- GLP-1与90天死亡率未校正OR 1.99(95%CI 1.55-2.56,p<0.01),校正年龄、SOFA评分、IL-6后OR 2.02(95%CI 1.23-3.31,p<0.01)。
- GIP水平与死亡率无关,也与宿主反应生物标志物无关。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,循环GLP-1水平升高可能作为预后生物标志物,用于识别急性呼吸衰竭危重患者中预后更差者。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) have therapeutic effects in diabetes mellitus. Prior clinical studies suggest incretins are prognostic of adverse outcomes in critical illness. We investigated whether incretin levels indicate disease severity and clinical outcomes in patients with acute respiratory failure, a common cause of critical illness.
DESIGN: Retrospective cohort study.
SETTING: ICUs in UPMC Health Systems hospitals within Western Pennsylvania.
PATIENTS: Two hundred ninety-seven critically ill adults with acute respiratory failure.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We measured GLP-1 and GIP levels in baseline samples collected at the time of study enrollment. We compared incretin levels across subgroups differing by severity of illness and investigated associations between incretins and markers of systemic host responses and intestinal permeability. In our primary analysis, we tested the association of each incretin level with 90-day mortality by logistic regression in unadjusted analyses and in analyses adjusted for age, Sequential Organ Failure Assessment score, and circulating interleukin-6 levels. GLP-1 levels were higher in nonsurvivors and patients with or at-risk for acute respiratory distress syndrome compared to those intubated for airway protection. GLP-1 levels also positively correlated with systemic immune response biomarkers but not with markers of intestinal permeability. GLP-1 levels positively correlated with mortality in unadjusted (odds ratio, 1.99 [1.55-2.56]; p < 0.01) and adjusted (2.02 [1.23-3.31]; p < 0.01) analyses. GIP levels were not associated with mortality or with host response biomarkers.
CONCLUSIONS: GLP-1 but not GIP levels were positively associated with systemic inflammation and mortality in critically ill patients with acute respiratory failure. Increased circulating GLP-1 levels may serve as prognostic biomarkers to identify patients who are likely to have worse outcomes.
参考来源
- Hansell CE, Aneis HA, Kitsios GD, et al. Glucagon-Like Peptide-1 Is Prognostic of Mortality in Acute Respiratory Failure. Crit Care Explor. 2025. PMID: 40126931. doi:10.1097/CCE.0000000000001247
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。